pharma · Parkinson's Disease · PARKINSON DISEASE (Disorder) · SER
Serina Therapeutics
Serina Therapeutics patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Huntsville, USA
- Founded
- 2007
- Employees
- 23
- Programs
- 2
- Drugs
- 3
- Patents
- 25
Serina Therapeutics patents
25 pharmaceutical patents indexed for Serina Therapeutics. 0 expire within 24 months.
Serina Therapeutics has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12383625
Polyoxazoline-drug conjugates with novel pharmacokinetic properties
granted -
US 12383626
Polyoxazoline-drug conjugates with novel pharmacokinetic properties
granted -
US 12233132
Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
granted -
US 11944618
Subcutaneous delivery of polymer conjugates of therapeutic agents
granted -
US 11925689
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 11766432
Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same
granted -
US 11298350
Subcutaneous delivery of polymer conjugates of therapeutics agents
granted -
US 11224595
Subcutaneous delivery of poly(oxazoline) polymer conjugates
granted -
US 11213588
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 11065340
Polyoxazoline antibody drug conjugates
granted -
US 10864276
Activated polyoxazolines and conjugates and compositions comprising the same
granted -
US 10314837
Subcutaneous delivery of poly(oxazoline) polymer conjugates
granted -
US 10166294
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 10086084
Activated polyoxazolines and conjugates and compositions comprising the same
granted -
US 10071168
Polyoxazoline antibody drug conjugates
granted -
US 9284411
Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
granted -
US 9169354
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 8883211
Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
granted -
US 8597633
Subcutaneous delivery of poly(oxazoline) conjugates
granted -
US 8501899
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 8383093
Subcutaneous delivery of poly(oxazoline) conjugates
granted -
US 8110651
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 8101706
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 8088884
Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
granted -
US 7943141
Activated polyoxazolines and compositions comprising the same
granted
Frequently asked questions
How many patents does Serina Therapeutics have?
25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Serina Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.